Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 134,553,130
- Total 13F shares
- 47,565,663
- Share change
- +1,217,062
- Total reported value
- $44,391,185
- Put/Call ratio
- 8.3%
- Price per share
- $0.93
- Number of holders
- 80
- Value change
- +$933,718
- Number of buys
- 35
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690469101:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
5.6%
|
7,531,996
|
$8,887,755 | — | 30 Sep 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
4%
|
5,315,969
|
$6,272,843 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.2%
|
4,314,437
|
$5,091,036 | — | 30 Sep 2024 | |
| Madison Avenue Partners, LP |
13F
13D/G
|
Company |
4%
from 13D/G
|
4,116,773
|
$4,857,793 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
2.9%
|
3,853,818
|
$4,547,505 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
3,142,439
|
$3,708,078 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
2.1%
|
2,850,000
|
$3,363,000 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,847,334
|
$2,178,000 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,527,985
|
$1,803,022 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
1,463,838
|
$1,727,329 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,400,191
|
$1,652,225 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,361,455
|
$1,606,517 | — | 30 Sep 2024 | |
| Amit Rakhit PoA |
3/4/5
|
President and CMO |
—
mixed-class rows
|
817,806
mixed-class rows
|
$1,562,669 | — | 14 Jul 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
1,317,330
|
$1,554,617 | — | 30 Sep 2024 | |
| TLS Advisors LLC |
13F
|
Company |
0.57%
|
771,531
|
$910,000 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.55%
|
735,185
|
$867,518 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.54%
|
729,208
|
$860,465 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.47%
|
628,290
|
$741,382 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
480,225
|
$566,665 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
309,540
|
$365,257 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.19%
|
260,509
|
$307,000 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.16%
|
220,401
|
$260,073 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
165,830
|
$195,679 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
165,763
|
$195,600 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
161,808
|
$190,933 | — | 30 Sep 2024 | |
| Empowered Funds, LLC |
13F
|
Company |
0.11%
|
145,340
|
$171,501 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
130,279
|
$153,729 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
119,113
|
$140,553 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.08%
|
105,177
|
$124,109 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
104,011
|
$122,733 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.06%
|
86,289
|
$101,821 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
84,175
|
$99,328 | — | 30 Sep 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
74,875
|
$88,353 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
68,723
|
$81,088 | — | 30 Sep 2024 | |
| Jason Tardio |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
196,875
mixed-class rows
|
$60,469 | — | 22 Feb 2024 | |
| Thomas M. Perone Poa |
3/4/5
|
General Counsel, Secretary |
—
mixed-class rows
|
196,875
mixed-class rows
|
$60,469 | — | 22 Feb 2024 | |
| FMR LLC |
13F
|
Company |
0.04%
|
50,225
|
$59,265 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
47,880
|
$56,498 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
44,500
|
$52,510 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
43,952
|
$51,863 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
38,399
|
$45,311 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
38,230
|
$45,111 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
37,892
|
$44,712 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.03%
|
37,743
|
$44,537 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
34,086
|
$40,221 | — | 30 Sep 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
32,039
|
$37,806 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
31,489
|
$37,157 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
30,612
|
$36,122 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
29,337
|
$34,618 | — | 30 Sep 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.02%
|
29,329
|
$34,608 | — | 30 Sep 2024 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2024
As of 31 Dec 2024,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,565,663 shares.
The largest 10 holders included
TAKEDA PHARMACEUTICAL CO LTD, Rubric Capital Management LP, BlackRock, Inc., BVF INC/IL, Madison Avenue Partners, LP, VANGUARD GROUP INC, Siren, L.L.C., ACADIAN ASSET MANAGEMENT LLC, KENNEDY CAPITAL MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
75
Q4 2024 holders
80
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.